£20,000 in savings? Here’s how I’d aim to turn that into a £7,614 monthly second income!

Putting money into high-quality FTSE 100 and FTSE 250 shares can help investors unlock a life-changing second income over time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Rear View Of Woman Holding Man Hand during travel in cappadocia

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Charlie Munger famously said: “The first rule of compounding: Never interrupt it unnecessarily.” This tenet applies whether an investor has already built up a large second income or is still working towards one.

Therefore, it’s always a good idea to have some savings set aside for a rainy day. Back in the day, a rainy day would have made it difficult to work outdoors and earn income (hence the phrase).

Nowadays, it could be anything from a broken boiler to a poorly pet. The last thing an investor wants to do is sell stocks (potentially at a loss) to cover an unforeseen bill. So Cash ISAs definitely have a role to play.

But assuming this base is covered, I’d want the rest of my savings in a Stocks and Shares ISA over the long run. Here’s why.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Stairs and elevators

Put simply, stocks deliver better long-term returns than other asset classes, particularly cash.

This doesn’t mean they’re always a sure bet, mind. Reduced dividends, bear markets and crashes, and a myriad of other events (wars, pandemics, financial panics, etc.) do happen. Often unexpectedly.

That’s why the stock market tends to deliver superior returns over time. Investors want a higher potential rate of return for taking on all this extra risk. Otherwise, why bother putting oneself through the wringer?!

Also, as a general rule, stock markets take the stairs up and the elevator down. In other words, they rise steadily but can drop dramatically.

That’s why it’s important to take a long-term, Foolish approach to investing.

Of course, tuning out all the noise when things are going south isn’t easy. But it is possible to cultivate a patient mindset with enough experience.

Life-changing passive income

Long term, the blue-chip FTSE 100 has returned almost 8% a year on average, while the mid-cap FTSE 250 has delivered around 10.5%. Both figures are with dividends reinvested rather than spent.

If this record continues, a £20k lump sum equally invested across these indexes would turn into an eye-catching £304,406 over the next 30 years (excluding any ISA platform fees).

However, if I decided to invest a further £650 a month – the equivalent of £150 a week – along the way, my total would be transformed into a mighty £1,522,806. So, just over £1.5m!

From this, I could decide to take £91,368 a year in passive income from a 6%-yielding dividend portfolio. That’s the equivalent of a tax-free £7,614 monthly second income.

A world-class company

To achieve this, I’d build a portfolio with quality stocks like AstraZeneca (LSE: AZN).

There are a number of things I like here. For starters, the pharma giant has 12 blockbuster drugs (those generating $1bn in annual sales) as well as a gigantic pipeline of future potential wonder treatments.

Naturally, some won’t come to fruition, meaning clinical trial failures are an unavoidable risk. But I find Astra’s deep pipeline reassuring.

Second, the company remains extremely ambitious. It recently said it’s aiming to grow revenue by about 75% to $80bn by 2030.

This will be through the potential launch of 20 new medicines as well as growth in its existing oncology, biopharmaceuticals, and rare disease portfolio.

Given this possibility and the firm’s excellent recent record of execution, I find the stock’s forward price-to-earnings multiple of 18.7 attractive.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is 2026 the year the Diageo share price bounces back?

Will next year be the start of a turnaround for the Diageo share price? Stephen Wright looks at a key…

Read more »

Investing Articles

Here’s my top FTSE 250 pick for 2026

UK investors looking for under-the-radar opportunities should check out the FTSE 250. And 2026 could be an exciting year for…

Read more »

Yellow number one sitting on blue background
Investing Articles

Here’s my number 1 passive income stock for 2026

Stephen Wright thinks a 5.5% dividend yield from a company with a strong competitive advantage is something passive income investors…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Should I sell my Scottish Mortgage shares in 2026?

After a strong run for Scottish Mortgage shares, our writer wonders if he should offload them to bank profits in…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Down 35%! These 2 blue-chips are 2025’s big losers. But are they the best shares to buy in 2026?

Harvey Jones reckons he's found two of the best shares to buy for the year ahead, but he also acknowledges…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

State Pension worries? 3 investment trusts to target a £2.6m retirement fund

Royston Wild isn't worried about possible State Pension changes. Here he identifies three investment trusts to target a multi-million-pound portfolio.

Read more »

Smiling white woman holding iPhone with Airpods in ear
Dividend Shares

4 dirt-cheap dividend stocks to consider for 2026!

Discover four great dividend stocks that could deliver long-term passive income -- and why our writer Royston Wild thinks they’re…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

These fabulous 5 UK stocks doubled in 2025 – can they do it again next year?

These five UK stocks have more than doubled investors' money as the FTSE 100 surges. Harvey Jones wonders if they…

Read more »